Obesity has reached epidemic proportions globally, with more than 1 billion adults overweight - at least 300 million of them clinically obese. In Ayurveda, obesity is called ‘medoroga’. The detailed features and treatments of the disease have been described in an old Ayurvedic text, Charak and Sushrut Samhita. There are some native plants that are commonly used for the treatment of obesity in Ayurveda. Unfortunately, only few medications are available in the market, with side effects and unacceptable efficacy. With the current view that botanical drugs can be developed faster and more cheaply than conventional single entity pharmaceuticals, the review mainly focuses on the rationality of their use with appropriate literature data support.
MarciniMC, HalpernA. (2006) Pharmacological treatment of obesity. Arquivos Brasileiros de Endocrinologia and Metabologia, 50, 377–389.
7.
WeigleDS. (2003) Pharmacological therapy of obesity: Past, present, and future. The Journal of Clinical Endocrinology and Metabolism, 88, 2462–2469.
8.
ManciniMC, HalpernA. (2006) Investigational therapies in the treatment of obesity. Expert Opinion in Investigational Drugs, 15, 897–915.
9.
HalfordJC. (2006) Obesity drugs in clinical development. Current Opinion in Investigational Drugs, 7, 312–318.
10.
JandacekRJ, WoodsSC. (2004) Pharmaceutical approaches to the treatment of obesity. Drug Discovery Today, 9, 874–880.
11.
BrayGA, TartagliaLA. (2000) Medicinal strategies in the treatment of obesity. Nature, 404, 672–677.
12.
ParanjpeP, PatkiP, PatwardhanB. (1990) Ayurvedic treatment of obesity: Randomized, double-blind, placebo-controlled clinical trial. Journal of Ethnopharmacology, 29, 1–11.
13.
SaperRB, EisenbergDM, PhilipsRS. (2004) Common dietary supplements for weight loss. American Family Physician, 70, 1731–1738.
14.
TiwariAK, RaoM. (2002) Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Current Science, 83, 30–38.
15.
BentS, TiedtTN, OddenMC, ShlipakMG. (2003) The relative safety of ephedra compared with other herbal products. Annals of Internal Medicine, 138, 468–471.
16.
HadvaryP, LengsfeldH, WolferH. (1988) Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. The Biochemical Journal, 256, 357–361.
17.
MorenoDA, IlicN, PouleyA, BrasaemleDL, FriedSK, RaskinI. (2003) Inhibitory effects of grape seed extract on lipases. Nutrition, 19, 876–879.
18.
HanLK, TakakuT, LiJ, KimuraY, OkudaH. (1999) Anti-obesity action of oolong tea. International Journal of Obesity, 23, 98–105.
19.
HanLK, KimuraY, KawashimaM, TakakuT, TaniyamaT, TayashiT, ZengYN, OkudaH. (2001) Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. International Journal of Obesity, 25, 1459–1464.
20.
NakaiM, FukuiY, AsamiS, Toyoda-OnoY, IwashitaT, ShibataH, MitsunagaT, HashimotoF, KisoY. (2005) Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. Journal of Agricultural and Food Chemistry, 53, 4593–4598.
21.
HanLK, XuBJ, KimuraY, ZhengY, OkudaH. (2000) Platycodi Radix affects lipid metabolism in mice with high fat diet–induced obesity. Journal of Nutrition, 130, 2760–2764.
22.
HanLK, ZhengY, XuBJ, OkudaH, KimuraY. (2002) Saponins from Platycodi Radix ameliorate high fat diet–induced obesity in mice. Journal of Nutrition, 132, 2241–2245.
23.
ZaoHL, KimYS. (2002) Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay. Archives of Pharmacal Research, 25, 446–448.
24.
XuBJ, HanLK, ZhengYN, LeeJH, SungCK. (2005) In Vitro inhibitory effect of triterpenoidal saponins from Platycodi Radix on pancreatic lipase. Archives of Pharmacal Research, 28, 180–185.
25.
ZhaoHL, SimJS. ShimSH, HaYW, KangSS, KimYS. (2005) Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction. International Journal of Obesity, 29, 983–990.
26.
LeeIA, LeeJH, BaekNI, KimDH. (2005) Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin. Biological and Pharmaceutical Bulletin, 28, 2106–2110
27.
YamamotaM, ShimuraS, ItohY, OhsakaT, EgawaM, InoueS. (2000) Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. International Journal of Obesity, 24, 758–764.
NinomiyaK, MatsudaH, ShimodaH, NishidaN, KasajimaN, YoshinoT, MorikawaT, YoshikawaM. (2004) Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorganic and Medicinal Chemistry Letters, 14, 1943–1946.
30.
MorenoDA, IlicN, PouleyA, RaskinI. (2006) Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sciences, 78, 2797–2803.
31.
ZhengQ, KoikeK, HanLK, OkudaH, NikaidoT. (2004) New biologically active triterpenoid saponins from Scabiosa tschiliensis. Journal of Natural Products, 67, 604–613.
32.
MasayukiY, HiroshiS, NirihisaN, MikiT, HisashiM. (2002) Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lypophilic activities have mild antiobesity effects in rats. Journal of Nutrition, 132, 1819–1834.
33.
YoshizumiK, HiranoK, AndoH, HiraiH, IdaY, TsujiT, TanakaT, SatouchiK, TeraoJ. (2006) Lupane type saponins from leaves of Acanthopanax sessiliflorus and their inhibitory activity on pancreatic lipase. Journal of Agriculture and Food Chemistry, 54, 335–341.
34.
HanLK, ZhengYN, YoshikawaM.OkudaH, KimuraY. (2005) Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complementary and Alternative Medicine, 5, 9–18.
35.
ShinJE, HanMJ, KimDH. (2002) 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase. Biological and Pharmaceutical Bulletin, 25, 1442–1445
36.
ShinJE, HanMJ, SongMC, BaekNI, KimDH. (2004) 5-Hydroxy-7-(4′-hydroxy-3′-methoxyphenyl)-1-phenyl-3-heptanone: A pancreatic lipase inhibitor isolated from Alpinia officinarum. Biological and Pharmaceutical Bulletin, 27, 138–140.
37.
HanLK, LiDX, XiangL, GongXJ, KondoY, SuzukiI, OkudaH. (2006) Isolation of pancreatic lipase inhibitor component of Spirulina platensis and it reduce postprandial triacylglycerolemia. Yakugaku Zasshi, 126, 43–49.
38.
YoungKH, HuiKM. (2005) Screening of Korean medicinal plants for lipase inhibitory activity. Phytotherapy Research, 19, 359–361.
39.
SharmaN, SharmaV, SeoS. (2005) Screening of some medicinal plants for anti-lipase activity. Journal of Ethnopharmacology, 97, 453–456.
40.
SlancP, DoljakB, MlinaricA, StukljB. (2004) Screening of wood damaging fungi and macrofungi for inhibitors of pancreatic lipase. Phytotherapy Research, 18, 758–762.
41.
ChenHC, FareseRV. (2005) Inhibition of triglyceride synthesis as a treatment strategy for obesity lessons from DGAT1-deficient mice. Arteriosclerosis Thrombosis and Vascular Biology, 25, 482–486.
42.
ChungMY, RhoMC, LeeSW, ParkHR, KimK, LeeIA, Dong (2006) Inhibition of diacylglycerol acyltransferase by betulinic acid from Alnus hirsuta, Planta Medica, 72, 267–269.
43.
ChungMY, RhoMC, KoJS, RyuSY, JeuneKH, KimK, LeeHS, KimYK. (2004) In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Medica, 70, 258–260.
44.
KoJS, RhoMC, ChungMY, SongHY, KangJS, KimK, LeeHS, KimYK. (2002) Quinolone alkaloids, diacylglycerol acyltransferase inhibitors from the fruits of Evodia rutaecarpa. Planta Medica, 68, 1131–1133.
45.
KobayashiY, NakanoY, KizakiM, HoshikumaK, YokooY, KamiyaT. (2001) Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Medica, 67, 628–633.
46.
HanLK, SumiyoshiM, ZhangJ, LiuMX, ZhangXF, ZhengYN, OkudaH, KimuraY. (2003) Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals. Phytotherapy Research, 17, 1188–1194.
47.
HanLK, SumiyoshiM, ZhengYN, OkudaH, KimuraY. (2003) Anti-obesity action of Salix matsudana leaves (Part 2). Isolation of anti-obesity effectors from polyphenol fractions of Salix matsudana. Phytotherapy Research, 17, 1195–1198.
48.
KoJS, RyuSY, KimYS, ChungMY, KangJS, RhoMC, LeeHS, KimYK. (2002) Inhibitory activity of diacylglycerol acyltransferase by tanshinones from the root of Salvia miltiorrhiza. Archives of Pharmacal Research, 25, 446–448.
49.
HallerCA, JacobP, BenowitzNL. (2004) Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clinical Pharmacology and Therapeutics, 75, 259–273.
50.
PreussHG, Di FerdinandoD, BagchiM, BagchiD. (2002) Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. Journal of Medicine, 33, 247–264.
51.
BermanA, MyersA. (2004) Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Experimental Biology and Medicine, 229, 698–704.
52.
ChantreP, LaironD. (2002) Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine, 9, 3–8.
53.
DullooAG, SeydouxJ, GirardierL, ChantreP, VandermanderJ. (2000) Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. International Journal of Obesity and Related Metabolic Disorders, 24, 252–258.
54.
JuhelC, ArmandM, PafumiY, RosierC, VandermanderJ, LaironD. (2000) Green tea extract (AR25®) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro - Effects on lipid metabolism and mechanism of action. Journal of Nutritional Biochemistry, 11, 45–51.
55.
AsidaH, FuruyashikiT, NagayasuH, BesshoH, SakakibaraH, HashimotoT, KanazawaK. (2004) Anti-obesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. BioFactors, 22, 135–140.
56.
SaitoM, UenoM, OginoS, KuboK, NagataJ, TakeuchiM. (2005) High dose of Garcinia cambogia is effective in suppressing fat accumulation in developing male Zucker obese rats, but highly toxic to the testis. Food and Chemical Toxicology, 43, 411–419.
57.
OhiaS, OpereC, LeDayA, BagchiM, BagchiD, StohsSJ. (2002) Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Molecular and Cellular Biochemistry, 238, 89–103.
58.
KoshyAS, AnilaL, VijayalakshmiNR. (2001) Flavonoids from Garcinia cambogia lower lipid levels in hypercholesterolemic rats. Food Chemistry, 72, 289–294.
59.
SoniMG, BurdockGA, PreussHG, StohsSJ, OhiaSE, BagchiD. (2004) Safety assessment of (-) - hydroxycitric acid and Super CitriMax, a novel calcium/ potassium salt. Food Chemistry Toxicology, 42, 1513–1529.
60.
MorimotoC, SatohY, HaraM, InoueS, TsujitaeT, OkudaH. (2005) Anti–obese action of raspberry ketone. Life Sciences, 77, 194–204.
61.
CastonguayTW, BellingerLL. (1987) Capsaicin and its effects upon meal patterns, and glucagon and epinephrine suppression of food intake. Physiology and Behavior, 40, 337–342.
62.
PreussHG, BagchiD, BagchiM, RaoCV, DeyDK, SatyanarayanaS. (2004) Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes, Obesity and Metabolism, 6, 171–180.
63.
WoodgateDE, ConquerJA. (2003) Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: A six-week exploratory study. Current Therapeutic Research, 64, 248–262.
64.
WalkerEA, StewartPM. (2003) 11Beta-hydroxysteroid dehydrogenase: unexpected connections. Trends in Endocrinology and Metabolism, 14, 334–339.
65.
LiRS, NakagawaY, NakanishiT, FujisawaY. (2004) Different responsiveness in body weight and hepatic 11 beta-hydroxysteroid dehydrogenase (11β-HSD) type 1 m-RNA to 11-beta-HSD inhibition by glycyrrhetinic acid treatment in obese and lean zucker rats. Metabolism, 53, 600–606.
66.
BordiaA, VermaSK, SrivastavaKC. (1997) Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenum-graecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 56, 379–384.
67.
GebhardtR. (1993) Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids, 28, 613–619.
68.
LiuL, YehYY. (2000) Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic. Lipids, 35, 197–203.
69.
MatsuuraH. (2001) Saponins in garlic as modifiers of the risk of cardiovascular disease. Journal of Nutrition, 131, 1000S–1005S.
70.
SatyavatiGV. (1991) Guggulipid: a promising hypolipidemic agent from gum guggul (Commiphora wightii). Economic and Medicinal Plant Research, 5, 47–82.
71.
SatyavatiGV, DwarakanathC, TripathiSN. (1969) Experimental studies on the hypocholesterolemic effect of Commiphora mukul. Engl (Guggul). Indian Journal of Medicinal Research, 57, 1950–1962.
72.
SinghV, KaulS, ChanderR, KapoorNK. (1990) Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats. Pharmacology Research, 22, 37–44.
73.
ThompsonJS, ErnstE. (2003) Herbs for serum cholesterol reduction: A systematic review. The Journal of Family Practice, 52, 468–478.
74.
NityanandS, SrivastavaJS, AsthanaOP. (1989) Clinical trials with guggulipid: A new hypolipidaemic agent. The Journal of the Association of Physicians of India, 37, 323–328.
75.
TripathiYB, MalhotraOP, TripathiSN. (1984) Thyroid stimulating action of Z-guggulsterone obtained from Commiphora mukul. Planta Medica, 50, 78–80.
76.
PandaS, KarA. (1999) Gugulu (Commiphora mukul) induces triiodothyronine production: Possible involvement of lipid peroxidation. Life Sciences, 65, PL137–PL141.
77.
PatilVD, NayakUR, Sukhdev (1972) Chemistry of Ayurvedic crude drugs-I Guggulu (resin from Commiphora mukul)-1: Steroidal constituents. Tetrahedron, 28, 2341–2352.
78.
PatilVD, NayakUR, Sukhdev (1972) Chemistry of ayurvedic crude drugs-II Guggulu (resin from Commiphora mukul)-2: Diterpenoid constituents. Tetrahedron, 29, 341–348.
ChanderR, KhannaAK, KapoorNK. (1996) Lipid lowering activity of guggulsterone from Commiphora mukul in hyperlipaemic rats. Phytotherapy Research, 10, 508–511.
81.
UrizarNL, LivermanAB, DoddsDT, SilvaFV, OrdentlichP, YanY, GonzalezFJ, HeymanRA, MangelsdorfDJ, MooreDD. (2002) A natural product that lowers cholesterol as an antagonist ligand for FXR. Science, 296, 1703–1706.
82.
WuJ, XiaC, MeierJ, LiS, HuX, LalaDS. (2002) The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Molecular Endocrinology, 16, 1590–1597.
83.
BhandariU, SharmaJN, ZafarR. (1998) The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. Journal of Ethnopharmacology, 61, 167–171.
84.
TanabeM, ChenYD, SaitoK, KanoY. (1993) Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chemical and Pharmaceutical Bulletin, 42, 710–713.
BabuPS, SrinivasanK. (1997) Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Molecular and Cellular Biochemistry, 166, 169–175.
87.
MathurR, SharmaA, DixitVP, VarmaM. (1996) Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. Journal of Ethnopharmacology, 50, 61–68.
88.
AnilaL, VijayalakshmiNR. (2002) Flavonoids from Emblica officinalis and Mangifera indica - effectiveness for dyslipidemia. Journal of Ethnopharmacology, 79, 81–87.
89.
RodriguezTS, GiménezDG, VázquezRD. (2002) Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine, 9, 687–693.
90.
GebhardtR. (2002) Prevention of taurolithocholate-induced hepatic bile canalicular distortions by HPLC-characterized extracts of artichoke (Cynara scolymus) leaves. Planta Medica, 68, 776–779.
91.
GebhardtR. (1998) Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts. The Journal of Pharmacology and Experimental Therapeutics, 286, 1122–1128.
92.
ShimodaaH, NinomiyaaK, NishidaN, YoshinoT, MorikawaT, MatsudaH, YoshikawaM. (2003) Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorganic and Medicinal Chemistry Letters, 13, 223–228.
93.
TurleySD, DietschyJM. (1995) Mechanisms of LDL-cholesterol lowering action of psyllium hydrophilic mucilloid in the hamster. Biochimica Biophysica Acta, 1255, 177–184.
94.
TurleySD, DaggyBP, DietschyJM. (1991) Cholesterol-lowering action of psyllium mucilloid in the hamster: sites and possible mechanisms of action. Metabolism, 40, 1063–1073.
95.
RajendranS, DeepalakshmiPD, ParasakthyK, DevarajH, DevarajSN. (1996) Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis, 123, 235–241.
96.
RamA, LauriaP, GuptaR, KumarP, SharmaVN. (1996) Hypocholesterolaemic effects of Terminalia arjuna tree bark. Journal of Ethnopharmacology, 55, 165–169.
97.
ShailaHP, UdupaSL, UdupaAL. (1998) Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. International Journal of Cardiology, 67, 119–124.
98.
ShuklaR, GuptaS, GambhirJK, PrabhuKM, MurthyPS. (2004) Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholesterolaemic rabbits. Journal of Ethnopharmacology, 92, 47–51.
99.
RamA, LauriaP, GuptaR, KumarP, SharmaVN. (1996) Hypolipidaemic effects of Myristica fragrans fruit extract in rabbits. Journal of Ethnopharmacology, 55, 49–53.
100.
ChuS, QuW, PangX, SunB. (2003) Effect of saponin from Tribulus terrestris on hyperlipidemia. Zhong Yao Cai, 26, 341–344.
101.
RamaswamyM, YauE, WasanKM, BoulangerKD, LiM, PritchardPH. (2002) Influence of phytostanol phosphoryl ascorbate, FM-VP4, on pancreatic lipase activity and cholesterol accumulation within Caco-2 cells. Journal of Pharmacy and Pharmaceutical Science, 5, 29–38.
102.
LooijeNA, RisovicV, StewartDJ, DebeyerD, KutneyJ, WasanKM. (2005) Disodium ascorbyl phytostanyl phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model. Journal of Pharmacy and Pharmaceutical Science, 8, 400–408.
103.
SenanayakeGVK, MaruyamaaM, ShibuyaK, SakonoM, FukudaN, MorishitaT, YukizakiC, KawanoM, OhtaH. (2004) The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. Journal of Ethnopharmacology, 91, 257–262.
104.
ChaturvediP, GeorgeS, MilinganyoM, TripathiYB. (2004) Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytotherapy Research, 18, 954–956.
105.
PrincePSM, MenonVP, GunasekaranG. (1999) Hypolipidaemic action of Tinospora cordifolia roots in alloxan diabetic rats. Journal of Ethnopharmacology, 64, 53–57.
106.
SharmaSB, NasirA, PrabhuKM, MurthyPS, MurthyD. (2003) Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology, 85, 201–206.
